
February 12, 2018
Peripheral Vasopressors: Safe or Dangerous?
Background: We have discussed the safety of peripheral vasopressors on REBEL EM before. In that review by Loubani et al was a systematic review of 85 articles and 270 patients. 95% of the extravasation events occurred in PIVs with infusions running greater than 4 hours and 85% of extravasation events occurred in PIVs distal to the antecubital fossa. The major limitation of this systematic review is that the majority of the data was derived from case reports and case series and not prospective trials. The authors of this current study sought to determine the incidence of complications of running vasopressors through PIVs in patients with circulatory shock in a prospective, observational trial.
What They Did:
- Prospective observational study of patients with circulatory shock receiving vasopressors through a peripheral IV
- Determine the complication rate from administration of vasopressors through peripheral IVs
Outcomes:
- Primary: Complication rate
- Minor Complications: drug extravasation, thrombophlebitis, and localized cellulitis
- Major Complications: tissue necrosis and limb ischemia
Inclusion:
- Patients presenting to the ED with circulatory shock
- Vasopressor initiation through a PIV
Exclusion:
- Refusal of consent (13 patients could not be recruited)
Results:
- 55 patients included
- In-Hospital Mortality Rate: 32.1%
- Types of Shock:
- Septic: 83.6%
- Cardiogenic: 10.9%
- Hypovolemic/Hemorrhagic: 5.5%
- Vasopressors Used:
- Norepinephrine: 90.9%
- Dopamine 9.1%
- Site of PIV
- External Jugular: 3.6%
- Upper Arm: 1.8%
- Antecubital Fossa: 40%
- Forearm: 18.2%
- Hand 36.4%
- Catheter Gauge
- 16: 10.9%
- 18: 36.4%
- 20: 50.9%
- 22: 1.8%
- Median Duration of Vasopressor Infusion (Hrs):
- Norepinephrine or Dopamine: 14 (Range 7 – 40)
- Norepinephrine: 13 (Range 6.5 – 31.5)
- Dopamine: 53 (15.5 – 113)
Strengths:
- Research fellows role was entirely observational and did not influence decisions
- IVs physically examined 2x/day during vasopressor infusion and then daily up to 48 hours after discontinuation of vasopressor
- Prospective study
Limitations:
- Small patient population
- Single center trial
- Only norepinephrine and dopamine were studied (i.e. would have been nice to have a real mix of pressors such as epinephrine, etc)
- No randomization
- No comparator group
Discussion:
- All 3 complications occurred in patients with 20g catheters, but due to the small number of complications it is difficult to conclude that 20g catheters should not be used
- Specifics of the 3 complications:
- Patient 1: Local thrombophlebitis. Norepinephrine (8mg in 250mL D5W) through 20g catheter in right hand. Vasopressor infused for 40hrs with maximal infusion rate of 7ug/min
- Patient 2: Skin Pallor. Norepinephrine (8mg in 250mL D5W) through 20g catheter in left hand. Vasopressor infused for 11hrs with maximal infusion rate 7ug/min
- Patient 3: Non-Blanching Skin Erythema. Norepinephrine (8mg in 250 ML D5W) through 20g catheter in antecubital fossa. Vasopressor infused for 28hrs with maximal infusion rate19ug/min
Author Conclusion: “The incidence of complications from the administration of vasopressors through a PVC is small and did not result in significant morbidity in this study. Larger prospective studies are needed to better determine the factors that are associated with these complications, and identify patients in whom this practice is safe.”
Clinical Take Home Point: In patients with shock, use of peripheral vasopressors (Norepinephrine and Dopamine) in a large bore IV (18 – 20g) at a proximal site (antecubital fossa or more proximal) run for ≤4hrs or less is a safe option until more central access can be achieved.
References:
- Medlej K et al. Complications from Administration of Vasopressors Through Peripheral Venous Catheters: An Observational Study. JEM 2018. PMID: 29110979
For More Thoughts on This Topic Checkout:
- REBEL EM: Mythbuster – Administration of Vasopressors Through Peripheral Intravenous Acces
- PulmCrit: Do Phenylephrine and Epinephrine Require Central Access
- EMCrit: Peripheral Vasopressor Infusions and Extravasation
- PulmCast: Peripheral Vasopressors – Are my days of Placing Central Lines Over? Not Yet?
Post Peer Reviewed By: Anand Swaminathan swisstimepieces (Twitter: @EMSwami)
Salim Rezaie
Latest posts by Salim Rezaie (see all)
- REBEL Cast Ep94: The ITACTIC Trial – Viscoelastic Hemostatic Assay Augmented Protocols - January 11, 2021
- What I Have Learned About Intermittent Fasting - January 5, 2021
- Blunt Cerebrovascular Injury (BCVI): Universal Imaging for All? - December 28, 2020
AXEL ELLRODT
Posted at 16:33h, 12 FebruaryHello there,
3/55 complicatios (minor) .
But what is the standard deviation ? It could be wide in such a sall trial.
(Cant’ access the paper)
Salim Rezaie
Posted at 17:03h, 12 FebruaryHey there Axel,
This was an observational trial, so no standard deviations were reported, just what the authors observed, which was 3/55 minor complications. The good news is, no bad long-term outcomes.
Salim
LITFL Review 319 | Edwin M. Thames
Posted at 11:48h, 19 February[…] Is peripheral vasopressors safe or dangerous? Read a great piece from R.E.B.E.L. EM on the latest evidence. [MMS] […]
LITFL Review 319 • LITFL Medical Blog • FOAMed Review
Posted at 07:21h, 07 September[…] Is peripheral vasopressors safe or dangerous? Read a great piece from R.E.B.E.L. EM on the latest evidence. [MMS] […]
AULA ABRAMEDE2018: Manejo da Via Aérea no Paciente Séptico (Assassinos POp) – Referências – Emergência Rules
Posted at 03:04h, 27 September[…] Peripheral Vasopressors: Safe or Dangerous?: https://rebelem.com/peripheral-vasopressors-safe-dangerous/ […]
prof prem raj pushpakaran
Posted at 05:24h, 02 Decemberprof prem raj pushpakaran writes — Ulf Svante von Euler, the great Swedish physiologist who discovered the neurotransmitter, norepinephrine, was born on February 7th 1905!!!
Crossing the line - EDEducate
Posted at 02:59h, 28 May[…] Peripheral Vasopressors: Safe or Dangerous?(2017). Salim Rezaie, Rebel EM […]
CENSER: Early Vasopressors in Septic Shock • The BREACH
Posted at 12:20h, 15 November[…] in the topic of peripheral vasopressors can find lots of interesting material on First10EM, REBEL EM, and in a post-hoc analysis study[3] published just last […]
Peripheral pressors: what's the risk? • The BREACH
Posted at 11:47h, 05 December[…] REBEL EM – Peripheral vasopressors: safe or dangerous?REBEL EM – Mythbuster: administration of vasopressors through peripheral IV accessFirst 10 EM – Peripheral vasopressors: the myth and the evidencePulmCrit – Do phenylephrine and epinephrine require central access?EM Crit – Peripheral vasopressor infusions and extravasation […]
An update on peripheral vasopressors - First10EM
Posted at 06:18h, 23 December[…] REBEL EM: Peripheral Vasopressors: Safe or Dangerous? […]